Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian H Kushner

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Pediatric Blood & Cancer|July 2, 2020
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastomaLeo Y Luo, Kim Kramer, Nai-Kong V Cheung, et al.
International Journal of Cancer|September 22, 2016
A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastomaBrian H Kushner, Nai-Kong V Cheung, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2020
Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease ProgressionIrene Y Cheung, Nai-Kong V Cheung, Shakeel Modak, et al.
International Journal of Cancer|March 20, 2014
Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastomaNai-Kong V Cheung, Irene Y Cheung, Kim Kramer, et al.
Pediatric Neurosurgery|January 22, 2004
Treatment of spinal involvement in neuroblastoma patientsDavid I Sandberg, Mark H Bilsky, Brian H Kushner, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2019
Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective TrialDana L Casey, Brian H Kushner, Nai-Kong V Cheung, et al.
Cancer|March 3, 2015
Osteochondroma in long-term survivors of high-risk neuroblastomaBrian H Kushner, Stephen S Roberts, Danielle N Friedman, et al.
Journal of Pediatric Hematology/Oncology|July 11, 2017
Long-term Pulmonary Outcomes in Pediatric Survivors of High-risk NeuroblastomaAnne Stone, Danielle Novetsky Friedman, Stefan Worgall, et al.
International Journal of Radiation Oncology, Biology, Physics|October 23, 2012
Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experienceNeil B Desai, Nicholas F Stein, Michael P LaQuaglia, et al.
Pediatric Blood & Cancer|August 14, 2019
Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastomaAnne Stone, Danielle Novetsky Friedman, Brian H Kushner, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Pediatric Blood & Cancer|July 2, 2020
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastomaLeo Y Luo, Kim Kramer, Nai-Kong V Cheung, et al.
International Journal of Cancer|September 22, 2016
A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastomaBrian H Kushner, Nai-Kong V Cheung, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2020
Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease ProgressionIrene Y Cheung, Nai-Kong V Cheung, Shakeel Modak, et al.
International Journal of Cancer|March 20, 2014
Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastomaNai-Kong V Cheung, Irene Y Cheung, Kim Kramer, et al.
Pediatric Neurosurgery|January 22, 2004
Treatment of spinal involvement in neuroblastoma patientsDavid I Sandberg, Mark H Bilsky, Brian H Kushner, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2019
Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective TrialDana L Casey, Brian H Kushner, Nai-Kong V Cheung, et al.
Cancer|March 3, 2015
Osteochondroma in long-term survivors of high-risk neuroblastomaBrian H Kushner, Stephen S Roberts, Danielle N Friedman, et al.
Journal of Pediatric Hematology/Oncology|July 11, 2017
Long-term Pulmonary Outcomes in Pediatric Survivors of High-risk NeuroblastomaAnne Stone, Danielle Novetsky Friedman, Stefan Worgall, et al.
International Journal of Radiation Oncology, Biology, Physics|October 23, 2012
Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experienceNeil B Desai, Nicholas F Stein, Michael P LaQuaglia, et al.
Pediatric Blood & Cancer|August 14, 2019
Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastomaAnne Stone, Danielle Novetsky Friedman, Brian H Kushner, et al.
Pageof 11